Sign In
to Vote &
Create Storyboards.
 
With this acquisition, Boston Scientific aims to gain share in the fast growing hysteroscopic (uterus related) surgery market. It could be easier for the company to enter this market with its non-traditional treatment approach now that the commonly-used methods (power morcellators) are coming under fire.
0
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard